Bovine Heparin - Global and China Top Players Market Share and Ranking 2023
According to Research, the global market for Bovine Heparin should grow from US$ 4589.3 million in 2022 to US$ 5568 million by 2029, with a CAGR of 2.8% for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Bovine Heparin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Bovine Heparin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinics grew percent.
Bovine Heparin is a medical material extracted from lung of cow.
This report studies and analyses global Bovine Heparin status and future trends, helps the client to determine the Bovine Heparin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Bovine Heparin, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Bovine Heparin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Bovine Heparin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Bovine Heparin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Bovine Heparin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Bovine Heparin key producing regions, capacity, production, and year over year growth
(6) Bovine Heparin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer
Bioibérica
Opocrin
Yino Pharma
Cisen Pharmaceutical
Sichuan Deebio Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Market segment by Type, covers
Unfractionated Heparin
Low Molecular Weight Heparin
Market segment by Application, can be divided into
Hospital
Clinics
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Bovine Heparin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Bovine Heparin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Bovine Heparin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Bovine Heparin, percent & CAGR, 2018-2029
Chapter 5: Bovine Heparin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Bovine Heparin Definition
1.2 Global Bovine Heparin Market Size and Forecast
1.2.1 By Consumption Value, Global Bovine Heparin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Bovine Heparin Market Size，2018-2029
1.2.3 Global Bovine Heparin Average Selling Price (ASP)，2018-2029
1.3 China Bovine Heparin Market Size and Forecast
1.3.1 By Consumption Value, China Bovine Heparin Market Size，2018-2029
1.3.2 By Sales Quantity, China Bovine Heparin Market Size，2018-2029
1.3.3 China Bovine Heparin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Bovine Heparin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Bovine Heparin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Bovine Heparin Market Share in Global, 2018-2029
1.4.3 Bovine Heparin Market Size: China VS Global, 2018-2029
1.5 Bovine Heparin Market Dynamics
1.5.1 Bovine Heparin Market Drivers
1.5.2 Bovine Heparin Market Restraints
1.5.3 Bovine Heparin Industry Trends
1.5.4 Bovine Heparin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Bovine Heparin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Bovine Heparin, Global Market Share by Company, 2018-2023
2.3 Bovine Heparin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Bovine Heparin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Bovine Heparin Concentration Ratio
2.6 Global Bovine Heparin Mergers & Acquisitions, Expansion Plans
2.7 Global Bovine Heparin Manufacturers Product Type
2.8 Head Office and Bovine Heparin Production Site of Key Manufacturer
2.9 Bovine Heparin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Bovine Heparin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Bovine Heparin, China Market Share by Company, 2018-2023
3.3 China Bovine Heparin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Bovine Heparin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Bovine Heparin Capacity by Region
4.3 Global Bovine Heparin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Bovine Heparin Production by Region, 2018-2029
4.5 Global Bovine Heparin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Bovine Heparin Industry Chain
5.2 Bovine Heparin Upstream Analysis
5.2.1 Bovine Heparin Core Raw Materials
5.2.2 Main Manufacturers of Bovine Heparin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Bovine Heparin Production Mode
5.6 Bovine Heparin Procurement Model
5.7 Bovine Heparin Industry Sales Model and Sales Channels
5.7.1 Bovine Heparin Sales Model
5.7.2 Bovine Heparin Typical Distributors
6 Sights by Type
6.1 Bovine Heparin Classification
6.1.1 Unfractionated Heparin
6.1.2 Low Molecular Weight Heparin
6.2 By Type, Global Bovine Heparin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Bovine Heparin Consumption Value, 2018-2029
6.4 By Type, Global Bovine Heparin Sales Quantity, 2018-2029
6.5 By Type, Global Bovine Heparin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Bovine Heparin Segment by Application
7.1.1 Hospital
7.1.2 Clinics
7.1.3 Others
7.2 By Application, Global Bovine Heparin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Bovine Heparin Consumption Value, 2018-2029
7.4 By Application, Global Bovine Heparin Sales Quantity, 2018-2029
7.5 By Application, Global Bovine Heparin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Bovine Heparin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Bovine Heparin Consumption Value, 2018-2029
8.3 By Region, Global Bovine Heparin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Bovine Heparin & Forecasts, 2018-2029
8.4.2 By Country, North America Bovine Heparin Market Size Market Share
8.5 Europe
8.5.1 Europe Bovine Heparin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Bovine Heparin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Bovine Heparin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Bovine Heparin Market Size Market Share
8.7 South America
8.7.1 South America Bovine Heparin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Bovine Heparin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Bovine Heparin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Bovine Heparin Consumption Value, 2018-2029
9.3 By Country, Global Bovine Heparin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Bovine Heparin Market Size, 2018-2029
9.4.2 By Type, U.S. Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Bovine Heparin Market Size, 2018-2029
9.5.2 By Type, Europe Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Bovine Heparin Market Size, 2018-2029
9.6.2 By Type, China Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Bovine Heparin Market Size, 2018-2029
9.7.2 By Type, Japan Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Bovine Heparin Market Size, 2018-2029
9.8.2 By Type, South Korea Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Bovine Heparin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Bovine Heparin Market Size, 2018-2029
9.10.2 By Type, India Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Bovine Heparin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer Bovine Heparin Models, Specifications, and Application
10.1.3 Pfizer Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Bioibérica
10.2.1 Bioibérica Company Information, Head Office, Market Area, and Industry Position
10.2.2 Bioibérica Bovine Heparin Models, Specifications, and Application
10.2.3 Bioibérica Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bioibérica Company Profile and Main Business
10.2.5 Bioibérica Recent Developments
10.3 Opocrin
10.3.1 Opocrin Company Information, Head Office, Market Area, and Industry Position
10.3.2 Opocrin Bovine Heparin Models, Specifications, and Application
10.3.3 Opocrin Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Opocrin Company Profile and Main Business
10.3.5 Opocrin Recent Developments
10.4 Yino Pharma
10.4.1 Yino Pharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Yino Pharma Bovine Heparin Models, Specifications, and Application
10.4.3 Yino Pharma Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Yino Pharma Company Profile and Main Business
10.4.5 Yino Pharma Recent Developments
10.5 Cisen Pharmaceutical
10.5.1 Cisen Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Cisen Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.5.3 Cisen Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cisen Pharmaceutical Company Profile and Main Business
10.5.5 Cisen Pharmaceutical Recent Developments
10.6 Sichuan Deebio Pharmaceutical
10.6.1 Sichuan Deebio Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sichuan Deebio Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.6.3 Sichuan Deebio Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sichuan Deebio Pharmaceutical Company Profile and Main Business
10.6.5 Sichuan Deebio Pharmaceutical Recent Developments
10.7 Shenzhen Hepalink Pharmaceutical
10.7.1 Shenzhen Hepalink Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Shenzhen Hepalink Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.7.3 Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Shenzhen Hepalink Pharmaceutical Company Profile and Main Business
10.7.5 Shenzhen Hepalink Pharmaceutical Recent Developments
10.8 Yantai Dongcheng Pharmaceutical
10.8.1 Yantai Dongcheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Yantai Dongcheng Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.8.3 Yantai Dongcheng Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Yantai Dongcheng Pharmaceutical Company Profile and Main Business
10.8.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.9 Nanjing King-friend Biochemical Pharmaceutical
10.9.1 Nanjing King-friend Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.9.3 Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Nanjing King-friend Biochemical Pharmaceutical Company Profile and Main Business
10.9.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
10.10 Hebei Changshan Biochemical Pharmaceutical
10.10.1 Hebei Changshan Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Models, Specifications, and Application
10.10.3 Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Hebei Changshan Biochemical Pharmaceutical Company Profile and Main Business
10.10.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Bovine Heparin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Bovine Heparin Market Restraints
Table 3. Bovine Heparin Market Trends
Table 4. Bovine Heparin Industry Policy
Table 5. Global Bovine Heparin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Bovine Heparin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Bovine Heparin Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Bovine Heparin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Bovine Heparin Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Bovine Heparin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Bovine Heparin Mergers & Acquisitions, Expansion Plans
Table 12. Global Bovine Heparin Manufacturers Product Type
Table 13. Head Office and Bovine Heparin Production Site of Key Manufacturer
Table 14. Bovine Heparin Capacity of Major Manufacturers and Future Plan
Table 15. China Bovine Heparin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Bovine Heparin Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Bovine Heparin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Bovine Heparin Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Bovine Heparin Production by Region, 2018-2023, (Tons)
Table 20. Global Bovine Heparin Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Bovine Heparin Upstream (Raw Materials)
Table 22. Global Bovine Heparin Typical Customers
Table 23. Bovine Heparin Typical Distributors
Table 24. By Type, Global Bovine Heparin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Bovine Heparin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Bovine Heparin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Bovine Heparin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Bovine Heparin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Bovine Heparin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Bovine Heparin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Bovine Heparin Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Bovine Heparin Models, Specifications, and Application
Table 36. Pfizer Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Bioibérica Company Information, Head Office, Market Area, and Industry Position
Table 40. Bioibérica Bovine Heparin Models, Specifications, and Application
Table 41. Bioibérica Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Bioibérica Company Profile and Main Business
Table 43. Bioibérica Recent Developments
Table 44. Opocrin Company Information, Head Office, Market Area, and Industry Position
Table 45. Opocrin Bovine Heparin Models, Specifications, and Application
Table 46. Opocrin Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Opocrin Company Profile and Main Business
Table 48. Opocrin Recent Developments
Table 49. Yino Pharma Company Information, Head Office, Market Area, and Industry Position
Table 50. Yino Pharma Bovine Heparin Models, Specifications, and Application
Table 51. Yino Pharma Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Yino Pharma Company Profile and Main Business
Table 53. Yino Pharma Recent Developments
Table 54. Cisen Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 55. Cisen Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 56. Cisen Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Cisen Pharmaceutical Company Profile and Main Business
Table 58. Cisen Pharmaceutical Recent Developments
Table 59. Sichuan Deebio Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 60. Sichuan Deebio Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 61. Sichuan Deebio Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Sichuan Deebio Pharmaceutical Company Profile and Main Business
Table 63. Sichuan Deebio Pharmaceutical Recent Developments
Table 64. Shenzhen Hepalink Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 65. Shenzhen Hepalink Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 66. Shenzhen Hepalink Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Shenzhen Hepalink Pharmaceutical Company Profile and Main Business
Table 68. Shenzhen Hepalink Pharmaceutical Recent Developments
Table 69. Yantai Dongcheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Yantai Dongcheng Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 71. Yantai Dongcheng Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Yantai Dongcheng Pharmaceutical Company Profile and Main Business
Table 73. Yantai Dongcheng Pharmaceutical Recent Developments
Table 74. Nanjing King-friend Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 76. Nanjing King-friend Biochemical Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Nanjing King-friend Biochemical Pharmaceutical Company Profile and Main Business
Table 78. Nanjing King-friend Biochemical Pharmaceutical Recent Developments
Table 79. Hebei Changshan Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Models, Specifications, and Application
Table 81. Hebei Changshan Biochemical Pharmaceutical Bovine Heparin Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Hebei Changshan Biochemical Pharmaceutical Company Profile and Main Business
Table 83. Hebei Changshan Biochemical Pharmaceutical Recent Developments
List of Figures
Figure 1. Bovine Heparin Picture
Figure 2. Global Bovine Heparin Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Bovine Heparin Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Bovine Heparin Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Bovine Heparin Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Bovine Heparin Sales Quantity (Tons) & (2018-2029)
Figure 7. China Bovine Heparin Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Bovine Heparin Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Bovine Heparin Market Share of Global, 2018-2029
Figure 10. Global Bovine Heparin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Bovine Heparin Key Participants, Market Share, 2022
Figure 12. Global Bovine Heparin Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Bovine Heparin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Bovine Heparin Production Market Share & Forecast by Region, 2018-2029
Figure 15. Bovine Heparin Industry Chain
Figure 16. Bovine Heparin Procurement Model
Figure 17. Bovine Heparin Sales Model
Figure 18. Bovine Heparin Sales Channels, Direct Sales, and Distribution
Figure 19. Unfractionated Heparin
Figure 20. Low Molecular Weight Heparin
Figure 21. By Type, Global Bovine Heparin Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Bovine Heparin Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global Bovine Heparin Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Bovine Heparin Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Hospital
Figure 27. Clinics
Figure 28. Others
Figure 29. By Application, Global Bovine Heparin Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Bovine Heparin Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global Bovine Heparin Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Bovine Heparin Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global Bovine Heparin Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Bovine Heparin Sales Quantity Market Share, 2018-2029
Figure 36. North America Bovine Heparin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Bovine Heparin Consumption Value Market Share, 2022
Figure 38. Europe Bovine Heparin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Bovine Heparin Consumption Value Market Share, 2022
Figure 40. Asia Pacific Bovine Heparin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Bovine Heparin Consumption Value Market Share, 2022
Figure 42. South America Bovine Heparin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Bovine Heparin Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Bovine Heparin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 46. By Type, U.S. Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 49. By Type, Europe Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, China Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Japan Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, South Korea Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Southeast Asia Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, India Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Bovine Heparin Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Middle East & Africa Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Bovine Heparin Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|